Literature DB >> 18844214

TCEB1 promotes invasion of prostate cancer cells.

Sanni E Jalava1, Kati P Porkka, Hanna E Rauhala, Jarkko Isotalo, Teuvo L Tammela, Tapio Visakorpi.   

Abstract

Amplification of the long arm of chromosome 8 is one of the most recurrent findings in prostate cancer and it is associated with poor prognosis. Several minimal regions of amplification suggest multiple target genes which are yet to be identified. We have previously shown that TCEB1, EIF3S3, KIAA0196 and RAD21 are amplified and overexpressed in prostate cancer and they are located in the 8q area. In this study, we examined the functional effects of these genes to prostate cancer cell phenotype. We overexpressed and inhibited the genes by lentivirus mediated overexpression and RNA interference, respectively. shRNA mediated TCEB1 silencing decreased significantly cellular invasion of PC-3 and DU145 cells through Matrigel. TCEB1 silencing reduced the anchorage-independent growth of PC-3 cells. Similar effects were not seen with any other genes. When overexpressed in NIH 3T3 cells, TCEB1 and EIF3S3 increased the growth rate of the cells. Transcriptional profiling of TCEB1 silenced PC-3 cells revealed decrease of genes involved in invasion and metastasis. Finally, we also confirmed here the overexpression of TCEB1 in hormone-refractory prostate tumors. This study indicates that TCEB1 promotes invasion of prostate cancer cells, is involved in development of hormone-refractory prostate cancer and is thereby a strong candidate to be one of the target genes for the 8q gain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 18844214     DOI: 10.1002/ijc.23916

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  11 in total

1.  Challenges in identifying candidate amplification targets in human cancers: chromosome 8q21 as a case study.

Authors:  Jennifer A Byrne; Yuyan Chen; Nancy Martin La Rotta; Gregory B Peters
Journal:  Genes Cancer       Date:  2012-02

2.  Evaluation of cellular determinants required for in vitro xenotropic murine leukemia virus-related virus entry into human prostate cancer and noncancerous cells.

Authors:  Sushma Bhosle; Suganthi Suppiah; Ross Molinaro; Yuying Liang; Rebecca Arnold; William Diehl; Natalia Makarova; Jerry Blackwell; John Petros; Dennis Liotta; Eric Hunter; Hinh Ly
Journal:  J Virol       Date:  2010-04-21       Impact factor: 5.103

3.  Quantitative proteomic profiling of prostate cancer reveals a role for miR-128 in prostate cancer.

Authors:  Amjad P Khan; Laila M Poisson; Vadiraja B Bhat; Damian Fermin; Rong Zhao; Shanker Kalyana-Sundaram; George Michailidis; Alexey I Nesvizhskii; Gilbert S Omenn; Arul M Chinnaiyan; Arun Sreekumar
Journal:  Mol Cell Proteomics       Date:  2009-11-09       Impact factor: 5.911

4.  Allelic variation at the 8q23.3 colorectal cancer risk locus functions as a cis-acting regulator of EIF3H.

Authors:  Alan M Pittman; Silvia Naranjo; Sanni E Jalava; Philip Twiss; Yussanne Ma; Bianca Olver; Amy Lloyd; Jayaram Vijayakrishnan; Mobshra Qureshi; Peter Broderick; Tom van Wezel; Hans Morreau; Sari Tuupanen; Lauri A Aaltonen; M Eva Alonso; Miguel Manzanares; Angela Gavilán; Tapio Visakorpi; José Luis Gómez-Skarmeta; Richard S Houlston
Journal:  PLoS Genet       Date:  2010-09-16       Impact factor: 5.917

5.  Epigenetically altered miR-193b targets cyclin D1 in prostate cancer.

Authors:  Kirsi M Kaukoniemi; Hanna E Rauhala; Mauro Scaravilli; Leena Latonen; Matti Annala; Robert L Vessella; Matti Nykter; Teuvo L J Tammela; Tapio Visakorpi
Journal:  Cancer Med       Date:  2015-07-01       Impact factor: 4.452

6.  PRDM14 promotes the migration of human non-small cell lung cancer through extracellular matrix degradation in vitro.

Authors:  Hong-Xia Bi; Han-Bing Shi; Ting Zhang; Ge Cui
Journal:  Chin Med J (Engl)       Date:  2015-02-05       Impact factor: 2.628

7.  Sex difference in EGFR pathways in mouse kidney-potential impact on the immune system.

Authors:  Fengxia Liu; Yan Jiao; Yun Jiao; Franklin Garcia-Godoy; Weikuan Gu; Qingyi Liu
Journal:  BMC Genet       Date:  2016-11-24       Impact factor: 2.797

8.  Copy number variations of circulating, cell-free DNA in urothelial carcinoma of the bladder patients treated with radical cystectomy: a prospective study.

Authors:  Armin Soave; Felix K-H Chun; Timo Hillebrand; Michael Rink; Lars Weisbach; Bettina Steinbach; Margit Fisch; Klaus Pantel; Heidi Schwarzenbach
Journal:  Oncotarget       Date:  2017-05-07

9.  A comprehensive analysis of cancer-driving mutations and genes in kidney cancer.

Authors:  Chengmei Long; Jinbo Jian; Xinchang Li; Gongxian Wang; Jingen Wang
Journal:  Oncol Lett       Date:  2017-02-07       Impact factor: 2.967

10.  Screening Gene Expression-Related Alternative Splicing Event Signature for Colon Cancer Prognostic Prediction.

Authors:  Jie Xu; Jingfeng Chen; Chuan Cheng; Huixia Li; Peng Gao; Jiujian Zheng; Jianping Wang
Journal:  J Oncol       Date:  2022-01-27       Impact factor: 4.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.